Saturday 19 Apr, 2025 09:48 AM
Site map | Locate Us | Login
   Jio Financial Services Q4 PAT rises 2% YoY to Rs 316 cr    Infosys Q4 PAT rises 3% QoQ to Rs 7,038 cr; declares dividend of Rs 22/sh    HDFC Life Q4 PAT climbs 16% YoY to Rs 476 cr    HDFC AMC rises after Q4 PAT jumps 18% YoY to Rs 639 cr; declares final dividend of Rs 90/sh    Sonata Software drops amid lower Q4 revenue guidance    AGI Infra's housing project in Punjab gets RERA registration    Home First Finance gains after raising Rs 1,250 crore    Lupin gets EIR from USFDA for Nagpur facility    Sonata Software Ltd leads losers in 'A' group    Alkem Labs' subsidiary concludes acquisition of 100% stake in Bombay Ortho    Vikram Aroma Ltd leads losers in 'B' group    Awfis Space inks pact with ECOS Mobility for offering premium corporate transportation services    Volumes spurt at Fertilizers & Chemicals Travancore Ltd counter    E2E Networks rallies after multi-fold jump in Q4 PAT to Rs 13.61 cr    Gensol Engg slumps as SEBI unplugs promoters over alleged fraud 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Lupin gets EIR from USFDA for Nagpur facility
17-Apr-25   15:00 Hrs IST

The EIR was issued following an inspection of the facility conducted from 10 June to 13 June 2024.

Nilesh Gupta, Managing Director, Lupin, said, 'We are very pleased to have received the EIR from the US FDA for drug-device combination products at our Nagpur injectable facility. We remain committed to producing complex generic and essential products that address unmet needs.

Mumbai-based Lupin is an innovation-led, transnational pharmaceutical company. It develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the US, India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.

Lupin's consolidated net profit jumped 38.81% to Rs 858.86 crore on a 10.60% increase in sales to Rs 5,618.6 crore in Q3 FY25 compared to Q3 FY24.

Shares of Lupin rose 0.51% to Rs 1,945.65 on the BSE.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 40281741
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd